Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 15:13:1231420.
doi: 10.3389/fonc.2023.1231420. eCollection 2023.

Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice

Affiliations
Review

Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice

Chenyu Ma et al. Front Oncol. .

Abstract

Alpha-fetoprotein (AFP) is a commonly used clinical biomarker. Before 1970, the two-way agar diffusion method was mainly used, and the specificity of AFP in the diagnosis of primary liver cancer was satisfactory. However, its positivity rate was not very high. The diagnostic value of AFP is changing with the evolution of detection methods. Here, we performed a literature search to identify English-language publications. The search was performed from January 2015 to April 2023 using the PubMed database and the following terms in [Titles/Abstracts]: alpha-fetoprotein, clinical practice, detection, etc. The references of retrieved articles were also screened to broaden the search. Studies referring to liver cancer and AFP detection methods were excluded. In this review, several clinical application scenarios for AFP were systematically reviewed, and its potential detection value in the future was discussed.

Keywords: alpha-fetoprotein; clinical application; fetal diseases; pregnancy; tumor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Future research theme for the clinical applications of AFP in non-HCC diseases.

Similar articles

Cited by

References

    1. Chen E, Wei Y, Liu H, Tang C, Liu M, Peng K, et al. . Hepatoid adenocarcinoma of stomach: Emphasis on the clinical relationship with alpha-fetoprotein-positive gastric cancer. BioMed Res Int (2019) 2019:6710428. doi: 10.1155/2019/6710428 - DOI - PMC - PubMed
    1. Tayob N, Kanwal F, Alsarraj A, Hernaez R, El-Serag HB. The performance of afp, afp-3, dcp as biomarkers for detection of hepatocellular carcinoma (Hcc): A phase 3 biomarker study in the united states. Clin Gastroenterol Hepatol (2023) 21(2):415–23. doi: 10.1016/j.cgh.2022.01.047 - DOI - PMC - PubMed
    1. Wang X, Mao M, He Z, Zhang L, Li H, Lin J, et al. . Development and validation of a prognostic nomogram in afp-negative hepatocellular carcinoma. Int J Biol Sci (2019) 15(1):221–8. doi: 10.7150/ijbs.28720 - DOI - PMC - PubMed
    1. Chen S, Chen H, Gao S, Qiu S, Zhou H, Yu M, et al. . Differential expression of plasma microrna-125b in hepatitis b virus-related liver diseases and diagnostic potential for hepatitis b virus-induced hepatocellular carcinoma. Hepatol Res (2017) 47(4):312–20. doi: 10.1111/hepr.12739 - DOI - PubMed
    1. Liu L, Wang Q, Zhao X, Huang Y, Feng Y, Zhang Y, et al. . Establishment and validation of nomogram model for the diagnosis of afp-negative hepatocellular carcinoma. Front Oncol (2023) 13:1131892. doi: 10.3389/fonc.2023.1131892 - DOI - PMC - PubMed